Continuing the Prescription Drug Monitoring Program in accordance with the provisions of the Maryland Program Evaluation Act (Sunset Law) by extending to July 1, 2019, the termination provisions relating to the statutory and regulatory authority of the Program; authorizing the Program to disclose specified information to specified persons under specified circumstances; requiring the Department of Legislative Services to conduct a direct full evaluation of the Program on or before December 1, 2017; etc.
Bill File Type: Regular
Effective Date(s): July 1, 2014
( 21-2A-05, 21-2A-06, 21-2A-07, 21-2A-10 )
Last Updated: 2/3/2020 2:29 PM